Skip to main content
OpenTrials
Completed

NCT Number: NCT07789197

Validation and Cultural Adaptation of Jaw Functional Limitation Scale-20

Temporomandibular joint (TMJ) disorder (TMD) is common. Jaw Functional Limitation Scale-20 (JFLS) is a validated tool for the evaluation of patients suffering from TMD

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Larissa University Hospital

Larissa, Thessaly, 41110, Greece

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • adult patient >18 years old
  • native speakers of the Greek language
  • willing to participate

Exclusion criteria

  • any diagnosed neurocognitive dysfunction
  • any diagnosed systematic disease that forbids the participation in the study

Treatment and study plan

Primary outcomes

  1. Jaw Functional Limitation Scale-20

    Time frame: "From enrollment (baseline) to the end of assessment at 1 week"

    Patients suffering from TMJD will be assessed with the JFLS-20 for the validation and cultural adaptation of the JFLS-20 for the assessment of jaw functional limitation

Sponsors and collaborators

Lead sponsor

University of Thessaly

Other

Registry information

Official study title

Alidation and Cultural Adaptation of Jaw Functional Limitation Scale-20 in Greek Population

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Aug 27, 2026
Registry last updated
Aug 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.